

#2335 - Dr. Mary Talley Bowden
164 snips Jun 10, 2025
Dr. Mary Talley Bowden, a board-certified Otolaryngologist and sleep medicine specialist, shares her insights on the complexities of COVID-19 treatments and vaccine hesitancy. She discusses ethical concerns surrounding mRNA technology, the media's portrayal of alternative therapies, and personal experiences navigating controversies within the healthcare system. Bowden also emphasizes the importance of transparency in medical practices and challenges the influence of the pharmaceutical industry on treatment decisions. Her perspective sheds light on the ongoing debates about health freedom and patient care.
AI Snips
Chapters
Books
Transcript
Episode notes
Early COVID Treatment Journey
- Dr. Mary Talley Bowden started treating COVID patients early with symptom management and monoclonal antibodies without rationing.
- When monoclonals became hard to get, she turned to ivermectin despite the negative propaganda.
Ivermectin Safety and Effectiveness
- Ivermectin's safety was confirmed by its high LD50 and lack of overdose reports compared to common meds.
- Use of ivermectin proved effective in early COVID treatment in Dr. Bowden's experience.
Legal Battles Over Ivermectin Use
- Dr. Bowden faced multiple medical board complaints related to prescribing ivermectin, including a battle over hospital privileges to treat a dying patient.
- Despite legal challenges, she continues to fight to clear her name and help patients.